[{"Assets_0_Q3_USD":879944000.0,"CommonStockSharesOutstanding_0_Q3_shares":57749890.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-273344000.0,"NetIncomeLoss_1_Q3_USD":-112994000.0,"NetIncomeLoss_3_Q3_USD":-308922000.0,"StockholdersEquity_0_Q3_USD":727265000.0,"Ticker":"RARE","CIK":"1515673","name":"ULTRAGENYX PHARMACEUTICAL INC.","OfficialName":"Ultragenyx Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5418950849.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191106"}]